(3-(4-Azidophenyl)propionyl¹,D-Tyr(Me)²,Arg⁶,Arg⁸,Tyr-NH₂⁹)-Vasopressin trifluoroacetate salt carries a photoactivatable azidophenyl group and multiple aromatic modifications. The peptide retains a cyclic framework that stabilizes defined conformations. Its design supports photocrosslinking and binding-site mapping studies. Researchers employ it in receptor-interface analysis, structural probing, and analog comparison.
CAT No: C0130
CAS No:157702-46-0
Synonyms/Alias:(3-(4-Azidophenyl)propionyl¹,D-Tyr(Me)²,Arg⁶,Arg⁸,Tyr-NH₂⁹)-Vasopressin trifluoroacetate salt;
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.